Literature DB >> 2593769

Mitogenic activation of the human lymphocytes induce the release of proenkephalin derived peptides.

M R Padrós1, O Vindrola, P Zunszain, L Fainboin, S Finkielman, V E Nahmod.   

Abstract

Several reports indicate that enkephalins participate in lymphocyte proliferation and several events of the immune response. It has been proposed that peptides involved in these processes may originate in the nervous system or endocrine glands. We have found that human peripheral blood lymphocytes (PBL) activated with a mitogenic agent contain and release proenkephalin derived peptides. The kinetics of met-enkephalin and cryptic products of proenkephalin in PBL activated with phytohemaglutinin (PHA) were studied. Peptides were released to the supernatant of stimulated PBL, reaching the highest values after 18 to 24 hours. The material secreted corresponds to high, intermediate and low molecular weight peptides derived from proenkephalin, displaying met-enkephalin and synenkephalin (proenkephalin 1-70) immunoreactivity. Therefore, an intrinsic lymphocytic proenkephalin system is induced by PHA and may play an important role in the regulation of the immune response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2593769     DOI: 10.1016/0024-3205(89)90521-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Proenkephalin system in human polymorphonuclear cells. Production and release of a novel 1.0-kD peptide derived from synenkephalin.

Authors:  O Vindrola; M R Padrós; A Sterin-Prync; A Ase; S Finkielman; V Nahmod
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 2.  The transcriptional regulation of the preproenkephalin gene.

Authors:  G Weisinger
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

Review 3.  A "Drug-Dependent" Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV.

Authors:  María Amparo Assis; Pedro Gabriel Carranza; Emilio Ambrosio
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.